Tag: The Lancet Child & Adolescent Health

Palforzia Capsules with Logo

Results of Aimmune’s Pivotal Phase 3 European Trial of PALFORZIA® Published...

Peanut-allergic patients treated with Palforzia showed desensitization to peanut protein with a predictable safety profile at nine months
L-rhamnosus

Study: Peanut Oral Immunotherapy Combined with Probiotic Achieves Lasting Results

Exciting news of lasting peanut tolerance four years after Probiotic + Peanut OIT treatment.